APRIL 27, 2017, RESEARCH TRIANGLE PARK (RTP), North Carolina, USA and HEIDELBERG, Germany -- TCG (Technology Commercialization Group, LLC), an international life sciences firm headquartered in the RTP region of North Carolina with offices in Heidelberg has noticed a trend over the…
The April issue 2016 of In-Vivo – the Business Medicine Report led with an article on the importance of economic factors in US medical device development, authored by TCG Partners Ken West, Jim Woodward and Reinhard Merz. (https://www.pharmamedtechbi.com/publications/in-vivo/34/4/economics-will-drive-the-evolution-of-the-medical-device-industry). Contact TCG for more…
RESEARCH TRIANGLE PARK (RTP), North Carolina, USA and HEIDELBERG, Germany -- TCG (Technology Commercialization Group, LLC), an international life sciences firm headquartered in the Research Triangle Park region of North Carolina with offices in Heidelberg, Germany, is pleased to announce…
Chapel Hill, NC. (Business Wire) January 21, 2016 - Asklepios BioPharmaceutical, Inc. (AskBio) has entered into a license agreement granting Calimmune Inc. rights to AskBio’s Adeno-Associated Virus (AAV) gene therapy technologies. Charlie Turner, TCG Partner, led the completion of the license…
Research Triangle Park, NC and Heidelberg, DE - Technology Commercialization Group, LLC (TCG), an international firm providing interim management and strategic advisory services to life sciences companies, announced today that it had another successful quarter. Highlights of key accomplishments included:…
Research Triangle Park, NC - Technology Commercialization Group, LLC (TCG), an international firm providing interim management and strategic advisory services to life sciences companies, announced today that it has concluded another productive quarter in 2015. Below are highlights of the…
Click "Read more" and then click on the link for the press release: http://www.businesswire.com/news/home/20150617005099/en/Asklepios-AveXis-Finalize-License#.VYGFK-coF8F
Research Triangle Park, NC - Technology Commercialization Group, LLC (TCG), an international firm providing interim management and strategic advisory services to life sciences companies, announced today that it has concluded an active first quarter of 2015, with the hiring of…
Research Triangle Park, NC - Technology Commercialization Group, LLC (TCG), an international life science consulting firm specializing in interim management and strategic transaction services, is pleased to announce that Michael Garrett has joined the firm as a new Partner. Mr.…
Chapel Hill, NC - Initial trial results from Baxter hemophilia gene therapy program come from acquired affiliate of AskBio of Chapel Hill; TCG Partner Charlie Turner acted as interim business development leader in key transaction. Click here to download press…
